Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

GlaucomaOcular HypertensionOpen-Angle Glaucoma

Interventions

DRUG

Travoprost 0.004% ophthalmic solution

DRUG

Bimatoprost 0.01% ophthalmic solution